The efficacy of Ado-trastuzumab emtansine in HER-2 aberrant non-small cell lung cancer

Y. Xia (Hangzhou, China), X. Huang (Hangzhou, China), R. Jin (Hangzhou, China), W. Li (Hangzhou, China), H. Shen (Hangzhou, China)

Source: International Congress 2019 – Thoracic oncology: Treatment, diagnostic options and biology
Session: Thoracic oncology: Treatment, diagnostic options and biology
Session type: Thematic Poster
Number: 4669

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Y. Xia (Hangzhou, China), X. Huang (Hangzhou, China), R. Jin (Hangzhou, China), W. Li (Hangzhou, China), H. Shen (Hangzhou, China). The efficacy of Ado-trastuzumab emtansine in HER-2 aberrant non-small cell lung cancer. 4669

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: